Immunohistochemical analysis of the nm23 gene products in testicular seminoma

Pathology International

Volumn 47, Issue 5, 1997, Pages 288-292

  Hori, Kazutoshi ^a   Uematsu, Kunio ^a   Yasoshima, Hitoshi ^a   Sakurai, Kazunari ^a   Yamada, Akihiko ^a   Ohya, Munehiko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

neoplasm metastasis; nm23; nucleoside diphosphate kinase; seminoma; testis

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; MESSENGER RNA; NUCLEOSIDE DIPHOSPHATE KINASE;

ADOLESCENT; ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; SEMINOMA; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0030989074     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04495.x     Document Type: Article

References (26)

1. Germalluch JR, Climent MA, Villavicencio H et al. Treatment of stage I testicular tumours. Br. J. Urol. 1993; 71: 473-477.
2. Warde P, Gospodarowicz MK, Panzarella T et al. Stage I testicular seminoma: Results of adjuvant irradiation and surveillance. J. Clin. Oncol. 1995; 13: 2255-2262.
3. Hori K, Uematsu K, Yasoshima H, Sakurai K, Yamada A. Contribution of cell proliferative activity to malignancy potential in testicular seminoma. Pathol. Int. 1997; 5: 282-287
4. Steeg PS, Bevilacqua G, Kopper L et al. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl Cancer Inst. 1988; 80: 200-204.
5. Leone A, Flatow U, King CR et al. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991; 65: 25-35.
6. Leone A, Flatow U, VanHoutte K, Steeg PS. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993; 8: 2325-2333.
7. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991; 51: 445-449.
8. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer 1993; 55: 66-71.
9. Cohn KH, Wang F, DeSoto-LaPaix F et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 1991; 338: 722-724.
10. Wang L, Patel U, Ghosh L, Chen H-C, Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res. 1993; 53: 717-720.
11. Martinez JA, Prevot S, Nordlinger B et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 1995; 37: 712-720.
12. Yamaguchi A, Urano T, Goi T et al. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 1994; 73: 2280-2284.
13. Chandrasekharappa SC, Gross LA, King SE, Collins FS. The human NME2 gene lies within 18kb of NME1 in chromosome 17. Genes Chromosomes Cancer 1993; 6: 245-248.
14. Gilles AM, Presecan E, Vonica A, Lascu I. Nucleoside diphosphate kinase from human erythrocytes: Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J. Biol. Chem. 1991; 266: 8784-8789.
15. Higashiyama M, Doi O, Yokouchi H et al. Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br. J. Cancer 1992; 66: 533-536.
16. Gazzeri S, Brambilla E, Negoescu A et al. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: Association with tumor progression in squamous carcinoma. Lab. Invest. 1996; 74: 158-167.
17. Fujii K, Yasui W, Shimamoto F et al. Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas. Virchows Archiv. 1995; 426: 355-359.
18. Watanabe J, Sato Y, Kuramoto H, Kameya T. Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma. Br. J. Cancer 1995; 72: 1469-1473.
19. Sastre-Garau X, Lacombe ML, Jouve M, Véron M, Magdelénat H. Nucleoside diphosphate kinase/nm23 expression in breast cancer: Lack of correlation with lymph-node metastasis. Int. J. Cancer 1992; 50: 533-538.
20. Sawan ALI, Lascu I, Veron M et al. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: An immunohistochemical study. J. Pathol. 1994; 172: 27-34.
21. Radinsky R, Weisberg HZ, Staroselsky AN, Fidler IJ. Expression level of nm23 gene in clonal populations of metastatic murine and human neoplasms. Cancer Res. 1992; 52: 5808-5814.
22. Nakamori S, Ishikawa O, Ohhigashi H et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: An association with lymph node metastasis and tumor invasion. Clin. Exp. Metastasis 1993; 11: 151-158.
23. Leone A, Seeger RC, Hong CM et al. Evidence for nm23 overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993; 8: 855-865.
24. Morris VL, Tuck AB, Wilson SM, Percy D, Chambers AF. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines. Clin. Exp. Metastasis 1993; 11: 103-112.
25. Postel EH, Berberich SJ, Flint SJ, Ferrone CA. Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 1993; 261: 478-480.
26. Shuin T, Misaki H, Kubota Y, Yao M, Hosaka M. Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer 1994; 73: 1721-1727.